These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37121803)

  • 1. Socio-psychological determinants of second trimester maternal pertussis vaccination acceptance in the Netherlands.
    Immink MM; van der Maas NAT; de Melker HE; Ferreira JA; Bekker MN
    Vaccine; 2023 May; 41(22):3446-3453. PubMed ID: 37121803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands.
    Immink MM; Kemmeren JM; Broeders L; Bekker MN; de Melker HE; Sanders EAM; van der Maas NAT
    Vaccine; 2023 Jan; 41(5):1074-1080. PubMed ID: 36604217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants.
    Immink MM; Bekker MN; de Melker HE; Rots NY; Sanders EAM; van der Maas NAT
    BMC Infect Dis; 2021 Sep; 21(1):897. PubMed ID: 34479491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Strassberg ER; Power M; Schulkin J; Stark LM; Mackeen AD; Murtough KL; Paglia MJ
    Vaccine; 2018 Jul; 36(30):4548-4554. PubMed ID: 29907484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age.
    Romanin V; Acosta AM; Juarez MDV; Briere E; Sanchez SM; Cordoba BL; Sevilla ME; Lucion MF; Urrutia A; Sagradini S; Skoff TH; Vizzotti C
    Clin Infect Dis; 2020 Jan; 70(3):380-387. PubMed ID: 30877308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid--Michigan, 2011-2013.
    Housey M; Zhang F; Miller C; Lyon-Callo S; McFadden J; Garcia E; Potter R;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(38):839-42. PubMed ID: 25254561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women.
    Hall C; Abramovitz LM; Bukowinski AT; Ricker AA; Khodr ZG; Gumbs GR; Wells NY; Conlin AMS
    Vaccine; 2020 Feb; 38(8):1982-1988. PubMed ID: 31952872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tdap vaccine attitudes and utilization among pregnant women from a high-risk population.
    Dempsey AF; Brewer SE; Sevick C; Pyrzanowski J; Mazzoni S; O'Leary ST
    Hum Vaccin Immunother; 2016 Apr; 12(4):872-8. PubMed ID: 26430729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N
    Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Tdap and influenza vaccine uptake and its determinants in pregnancy: a cross-sectional study.
    Brillo E; Ciampoletti M; Tosto V; Buonomo E
    Ann Ig; 2022; 34(4):358-374. PubMed ID: 35195239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
    Van den Steen P; Cheuvart B; Deraedt Q; Valdes Verelst L; Shamarina D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2159731. PubMed ID: 36746754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and New York City, 2011.
    Ahluwalia IB; Ding H; D'Angelo D; Shealy KH; Singleton JA; Liang J; Rosenberg KD;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(19):522-6. PubMed ID: 25996094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring.
    Kerr SM; Van Bennekom CM; Mitchell AA
    Birth Defects Res; 2020 Mar; 112(5):393-403. PubMed ID: 31903700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social-psychological determinants of maternal pertussis vaccination acceptance during pregnancy among women in the Netherlands.
    Anraad C; Lehmann BA; Visser O; van Empelen P; Paulussen TGW; Ruiter RAC; Kamp L; van der Maas NAT; Barug D; Ruijs WLM; de Melker HE; Mollema L; van Keulen HM
    Vaccine; 2020 Sep; 38(40):6254-6266. PubMed ID: 32782189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
    Tsurane K; Umehara N; Nakayama T; Okada K; Inoue M; Ogawa K; Sago H; Miyasaka N; Yamaguchi K
    Vaccine; 2022 Nov; 40(49):7122-7129. PubMed ID: 36404430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
    Doraivelu K; Boulet SL; Biswas HH; Adams JC; Haddad LB; Jamieson DJ
    Vaccine; 2019 Sep; 37(41):6054-6059. PubMed ID: 31471152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB; Swamy GK; Broder KR; Jimenez-Truque N; Zhu Y; Moro PL; Liang J; Walter EB; Heine RP; Moody MA; Yoder S; Edwards KM
    Vaccine; 2018 Oct; 36(42):6354-6360. PubMed ID: 30219367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.